Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2

Am J Ophthalmol. 2002 Jan;133(1):168-9. doi: 10.1016/s0002-9394(01)01237-5.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial
  • Comment

MeSH terms

  • Choroidal Neovascularization / drug therapy*
  • Choroidal Neovascularization / etiology
  • Humans
  • Macular Degeneration / complications
  • Macular Degeneration / drug therapy*
  • Photochemotherapy*
  • Photosensitizing Agents / therapeutic use*
  • Porphyrins / therapeutic use*
  • Treatment Outcome
  • Verteporfin
  • Visual Acuity

Substances

  • Photosensitizing Agents
  • Porphyrins
  • Verteporfin